XTX Topco’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$64.7K Buy
2024
Q4
Sell
2024
Q3
$21.4K Sell
2024
Q2
$34.2K Buy
2024
Q1
$35.1K Sell
2023
Q4
$37.3K Sell
2023
Q3
$181K Buy
2023
Q2
Sell
2023
Q1
$76.9K Sell
2022
Q4
$274K Buy
2022
Q3
$126K Buy
2022
Q2
$50K Buy